Clinical Trials Sponsored by Avant Immunotherapeutics

Total 202 results

Avant Immunotherapeutics

Completed

Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery

Myocardial Ischemia | Mitral Valve Insufficiency | Aortic Valve Insufficiency | Coronary Arteriosclerosis

United States
Avant Immunotherapeutics

Completed

Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects

Typhoid Fever

United States
OSE Immunotherapeutics

Recruiting

To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults (COVEPIT 3)

Coronavirus Disease (COVID-19)

Belgium
Alladapt Immunotherapeutics, Inc.

Terminated

Open-label Extension Study of ADP101

Food Allergy

United States
Alladapt Immunotherapeutics, Inc.

Completed

ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults

Food Allergy

United States
OSE Immunotherapeutics

Recruiting

Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas

Lymphoma | Solid Advanced Tumor

France, Belgium
OSE Immunotherapeutics

Recruiting

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis (CoTikiS)

Ulcerative Colitis

Belgium, Latvia, Bulgaria, Belarus, Croatia, Georgia, Hungary, Poland, Russian Federation, South Africa, Ukraine
OSE Immunotherapeutics

Terminated

OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure (ATALANTE-1)

Non Small Cell Lung Cancer

France, Spain, Israel, United States, United Kingdom, Italy, Poland, Czechia, Germany, Hungary
OSE Immunotherapeutics

Completed

Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104

Rheumatoid Arthritis | Complication of Transplant

Belgium
Artielle ImmunoTherapeutics

Unknown

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting

United States
SIRPant Immunotherapeutics, Inc.

Recruiting

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin Lymphoma

United States
Elixiron Immunotherapeutics Inc.

Recruiting

First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers

Healthy

Australia
Brooklyn ImmunoTherapeutics, LLC

Completed

IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity (INSPIRE)

Squamous Cell Carcinoma of the Oral Cavity

United States, Brazil, United Kingdom, Canada
Heidelberg ImmunoTherapeutics GmbH

Terminated

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection (MATCH-1)

Herpes Labialis

Germany
RUTI Immunotherapeutics S.L.

Completed

Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers

Covid-19

Argentina
OSE Immunotherapeutics
Servier

Completed

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects

Healthy Subjects

Belgium
Innate Immunotherapeutics
Syneos Health

Completed

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis

New Zealand, Australia
MoonLake Immunotherapeutics AG

Completed

Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

Arthritis, Psoriatic

United States, Spain, Bulgaria, Poland, Czechia, Estonia, Germany, Hungary
MoonLake Immunotherapeutics AG

Completed

Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa

Germany, United States, Bulgaria, Canada, Ireland, Netherlands, Poland
Heidelberg ImmunoTherapeutics GmbH

Completed

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection (MATCH-2)

Herpes Genitalis

Germany
Brooklyn ImmunoTherapeutics, LLC

Completed

A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck
Elixiron Immunotherapeutics Inc.
Parexel

Completed

A Study to Evaluate the Safety, Tolerability and Amount of EI-1071 in Blood in Healthy Volunteers

Healthy Volunteers

United States
OSE Immunotherapeutics
Boehringer Ingelheim

Active, not recruiting

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

Solid Tumor, Adult

France, Belgium
Nantes University Hospital
OSE Immunotherapeutics

Active, not recruiting

Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study (FIRsT)

Kidney Transplantation

France
GERCOR - Multidisciplinary Oncology Cooperative...
OSE Immunotherapeutics

Recruiting

Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (TEDOPAM)

Metastatic Cancer | Pancreatic Ductal Adenocarcinoma | Locally Advanced Cancer

France
AIDS Healthcare Foundation
HIV Immunotherapeutics Institute

Completed

Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection

HIV-1-infection | Gut Inflammation

United States
Providence Health & Services
Brooklyn ImmunoTherapeutics, LLC

Active, not recruiting

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Breast Neoplasm | Triple Negative Breast Cancer | Breast Neoplasm, Male

United States
International Vaccine Institute
International Centre for Diarrhoeal Disease Research, Bangladesh; Christian... and other collaborators

Terminated

Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants

Diarrhea | Cholera | Vibrio Infections

Bangladesh, India
Avanti Anesthesia

Completed

Conscious Sedation Efficacy of the MKO Melt (Midazolam, Ketamine, Ondansetron)

Cataract

United States
Emory University
Bristol-Myers Squibb; Brooklyn ImmunoTherapeutics, LLC

Withdrawn

Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma | Stage II Oral Cavity Squamous Cell...

United States
Innate Immunotherapeutics
National Multiple Sclerosis Society; Primorus Clinical Trials

Completed

Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

New Zealand
Abant Izzet Baysal University

Not yet recruiting

Coronary Artery Disease and Exercise Adherence

Coronary Artery Disease | Adherence, Treatment
Abant Izzet Baysal University

Not yet recruiting

"Immediate Effect of DAFO on Gross Motor Function and Balance in Diplegic Cerebral Palsy

Diplegic Cerebral Palsy
Abant Izzet Baysal University

Not yet recruiting

Acute Coronary Syndrome and Acupressure

Acute Coronary Syndrome | Nursing
Abant Izzet Baysal University

Recruiting

Virtual Reality Based Mirror Therapy

Stroke | Upper Extremity Paralysis | Upper Extremity Paresis

Turkey
Abant Izzet Baysal University

Recruiting

Action Observation Training With 3D Virtual Reality in Patients With Multiple Sclerosis

Multiple Sclerosis

Turkey
Abant Izzet Baysal University

Recruiting

3D Resin Printed Fracture Models for Anatomy Education

Educational Problems | Anatomical Pathological Condition

Turkey
Abant Izzet Baysal University

Not yet recruiting

The Effect of Perineal Care Education on Palliative Care Patient' Relatives

Healthy
Abant Izzet Baysal University

Not yet recruiting

The Effect Of Model-Based Dıgıtal Game On Metabolıc Control, Self-Effıcıency And Qualıty Of Lıfe In Chıldren Wıth Type 1 Dıabetes

Type 1 Diabetes | Pediatric Nursing
Abant Izzet Baysal University

Recruiting

Application of Group Interpersonal Psychotherapy (IPT-G) to Family Members Caring for Patients With Schizophrenia (IPT-G)

Family Caregivers | Interpersonal Psychotherapy

Turkey
Abant Izzet Baysal University

Not yet recruiting

The Effect of Uncertainty in Heart Failure

Heart Failure With Reduced Ejection Fraction
Abant Izzet Baysal University

Not yet recruiting

Application of Platelet-Rich Fibrin on Diabetic Foot Wound

Diabetic Foot
Abant Izzet Baysal University

Recruiting

Comparison of Two Intervention in Children With Functional Constipation

Constipation - Functional | Pediatric

Turkey
Abant Izzet Baysal University

Recruiting

Musculoskeletal Problems and Endurance in Healthcare Professionals With and Without COVID-19

COVID-19 Respiratory Infection

Turkey
Abant Izzet Baysal University

Recruiting

The Effect of Respiratory Muscle Strength and Functional Capacity on Posture and Balance

Chronic Obstructive Pulmonary Disease

Turkey
Abant Izzet Baysal University

Recruiting

Respiratory Muscle Function, Diaphragm Thickness and Health Related Physical Fitness Parameters in Individuals

Chronic Obstructive Pulmonary Disease

Turkey
Abant Izzet Baysal University

Recruiting

Comparison of Respiratory Muscle Activations During Dyspnea Reduction Positions in Individuals

Chronic Obstructive Pulmonary Disease

Turkey
Abant Izzet Baysal University

Completed

A Cross Sectional Study on Dental Anxiety and State Anxiety Related to Removal of Fixed Partial Dentures

Dental Anxiety

Turkey
Abant Izzet Baysal University

Enrolling by invitation

The Effect of the Nursing Intervention Program on Adolescent Problematic Internet Users

Internet Addiction Disorder

Turkey
Abant Izzet Baysal University

Completed

Investigation of Palpation Pressure Sensitivity

Sensitivity Training Groups

Turkey

Clinical Trials Sponsored by Avant Immunotherapeutics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations